Fundraising Fox

Xylo

Sydney, AU · 33 employees on LinkedIn · 2 known investors

Xylo develops mechanism-based drug therapies targeting psychiatric and neurological disorders using computational and rational drug design approaches. The company serves patients and healthcare systems seeking novel treatments for complex neuropsychiatric conditions.

BiotechDeep TechDigital HealthHealthtech

Founders & leadership

JI
Joshua IsmininCo-founder, President
DS
Dr. Sam BanisterCo-founder, Chief Scientific Officer

Investors · 2

Radar Ventures
XEIA Venture PartnersSan Francisco

In the news

GovTech Startup Xylo Raises £2.8M Led by CapitalT to Solve Local Council Planning Bottlenecks | Industry | Priya Life Sciencepriyalifescience.com · Jul 2026Xylo Raises £2.8M Pre-seedthesaasnews.com · Jul 2026Mindflair-backed govtech AI firm Xylo raises £2.8m pre-seed funding - TipRanks.comtipranks.com · Jul 2026Xylo Secures £2.8 Million in Seed Funding Led by CapitalT | Raising.firaising.fi · Jul 2026Exclusive: DeepMind and Gensyn angels back Xylo in £2.8m raise | Siftedsifted.eu · Jun 2026Xylo Corporation Raises $100K Funding | Signalbasetrysignalbase.com · May 2026

Frequently asked questions

What does Xylo do?
Xylo develops mechanism-based drug therapies targeting psychiatric and neurological disorders using computational and rational drug design approaches. The company serves patients and healthcare systems seeking novel treatments for complex neuropsychiatric conditions.
Who founded Xylo?
Xylo was founded by Joshua Ismin, Dr. Sam Banister.
Who are Xylo's investors?
Xylo's investors include Radar Ventures, XEIA Venture Partners.
Where is Xylo headquartered?
Xylo is headquartered in Sydney, AU.